[Development of Schwartz-Bartter syndrome following administration of chlorpropamide and 1-deamino-8-D-arginine vasopressin].
D001127:Arginine Vasopressin / Q000031:analogs & derivatives*; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D048909:Diabetes Complications; D003919:Diabetes Insipidus / Q000150:complications / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged
D001127:Arginine Vasopressin; C025161:vasopressin, deamino-homo-Arg-; D003894:Deamino Arginine Vasopressin
Schwartz--Bartter syndroma kialakulása chlorpropamid, valamint I-deamino-8-D-arginin vasopressin adagolása után.